Effectiveness of lymphocytapheresis in a patient with ankylosing spondylitis
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Transfusion Science
- Vol. 11 (1) , 97-101
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.BMJ, 1986
- Cytotoxic T lymphocytes against disease-associated determinant(s) in ankylosing spondylitis.Journal of Experimental Medicine, 1986
- Sulphasalazine and Derivatives, Natural Killer Activity and Ulcerative ColitisClinical Science, 1985
- Characterization of human lymphocyte subpopulations: Alloreactive cytotoxic T-lymphocyte precursor and effector cells are phenotypically distinct from Leu 2+ suppressor cellsJournal of Clinical Immunology, 1984
- Soluble antigen-primed inducer T cells activate antigen-specific suppressor T cells in the absence of antigen-pulsed accessory cells: phenotypic definition of suppressor-inducer and suppressor-effector cells.The Journal of Immunology, 1984
- Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses.The Journal of Immunology, 1983
- Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.The Journal of Immunology, 1983
- Dissection of immunoregulatory subpopulations of T lymphocytes within the helper and suppressor sublineages in man.The Journal of Immunology, 1982
- Presence of circulating immune complexes in Reiter's syndrome and ankylosing spondylitisClinical Immunology and Immunopathology, 1981
- Evidence for a specific B27-associated cell surface marker on lymphocytes of patients with ankylosing spondylitisNature, 1979